Donanemab
0:49
Time saved in Alzheimer’s disease in Phase III trial of donanemab
Suzanne Hendrix
• 19 Jul 2023
1:26
Topline donanemab results: most positive Phase III data to date
Rebecca Edelmayer
• 18 May 2023